Financial Summary. Mitsui Chemicals, Inc. February 5, Results for 3 rd Quarter of FY2018 & Outlook for FY2018

Similar documents
Financial Summary. Mitsui Chemicals, Inc. November 1, Results of the 1 st Half of FY2018 & Outlook for FY2018

Financial Summary. Mitsui Chemicals, Inc. Aug 2, Results of the 1 st Quarter of FY2018 & Outlook for FY2018

Financial Summary. Mitsui Chemicals, Inc. May 12, Results of FY2016 & Outlook for FY2017. Copyright 2017 Mitsui Chemicals, Inc.

Summary of Consolidated Financial Results for Second Quarter of FY2017

Summary of Consolidated Financial Results for First Quarter of FY2018

Summary of Consolidated Financial Results for Third Quarter of FY2017

Supplementary Information on Financial Summary for the Nine Months of FY2014

Financial Summary Results of the First Quarter of FY2013 & Forecast for FY2013

Financial Summary. Mitsui Chemicals, Inc. Results of FY2012 & Forecast for FY2013. Copyright 2013 Mitsui Chemicals, Inc.

Financial Summary Results of the First Half of FY2012 & Forecast for FY2012

Financial Summary Results of Nine Months of FY & Outlook for FY2010

Financial Summary Results of the First Half of FY2011

Summary of Consolidated Financial Results for Second Quarter of FY2014

Financial Summary Results of Nine Months of FY2011 & Outlook for FY2011

Summary of Consolidated Financial Results for FY2017

Financial Summary. Mitsui Chemicals, Inc. February 3, Results of Nine Months of FY2009 & Outlook for FY2009

Financial Summary. Mitsui Chemicals, Inc. Results of FY2008 & Outlook for FY2009. Copyright 2009 Mitsui Chemicals, Inc.

Financial Summary Results of Nine Months of FY2012 & Forecast for FY2012

Summary of Consolidated Financial Results for FY2015

Summary of Consolidated Financial Results for FY2013

Supplementary Data for FY2013 Business Results (From

Supplementary Data for FY2012Q1 Business Results (From

Financial Results for FY2017. (Ended March 31, 2018)

1H of FY2016 (Jan. to Jun.) Earnings Presentation (Overview)

1Q of FY ending December 31, (0.2) (1.9) 11.3 (0.2) (0.2) (0.2) (0.2) (1.2) (89.2) 0.1

Financial Results for FY2016 (Ended March 31, 2017)

FY ended March 31, 2015 Restated *1. Year-on year change. Difference (forecast/ actual) FY ended December 31, December 31, 2015 Forecast *2

Six months of FY ending December 31, (0.4) (1.9) 22.5 (0.4) (0.3) (0.4) (0.1) (0.4) (0.7) (2.0) 0.9 (1.

Fully diluted net income per share

Financial Report 1st Quarter of FY2016 (From Apr. 1 to Jun. 30, 2016)

Financial Report The 1st Half of FY2015 (From Apr. 1 to Sep. 30, 2014)

Consolidated Financial Report for FY2000 Half-Year (April 1, 2000 September 30, 2000)

Year-on-year change (%) Ordinary income 52, Net assets equity ratio

Consolidated Financial Results for 3Q FY2018

Fully diluted net income per share Dividend per share (Record date) End of 1Q End of 2Q End of 3Q Year-end Annual

163, , , , , , , ,

Summary of Consolidated Financial Results. For the First Quarter of the Fiscal Year Ending March 31, (Three Months Ended June 30, 2018)

May 15, Sumitomo Chemical Co., Ltd.

GS Yuasa Corporation Consolidated Earnings Report for the. (Japanese GAAP)

242, , , , , , , ,

GS Yuasa Corporation Consolidated Earnings Report for the Nine Months ended December 31, 2018 (Japanese GAAP)

Consolidated Financial Results for the Fiscal Year Ended December 31, 2015 (January 1, 2015 to December 31, 2015)

Consolidated Interim Financial Statements - Summary (For the fiscal year ending March 31, 2007)

GS Yuasa Corporation Consolidated Earnings Report for the. (Japanese GAAP)

Condensed Consolidated Financial Information

FY ended December 31, 2015 Restated basis *1. Year-on-year change. FY ended December 31, 2016 Forecast *2. Difference (forecast/ actual)

Consolidated Financial Results for the Six Months Ended June 30, 2018 [Japanese GAAP]

[Translation] Code number: 1963 Representative Title: Representative Director, Chairman and Chief Executive Officer (CEO) Tel:

Net sales Operating profit Ordinary profit

Net sales Operating profit Ordinary profit. Million yen Million yen Million yen Million yen Six months ended

Financial Report For the year ended March 31, 2014 (April 1, 2013 to March 31, 2014)

2014 Mid-Term Business Plan

FY2018 Earnings Presentation (Overview)

Consolidated Financial Results for 3Q FY2017

Consolidated Financial Results for the Three Months Ended June 30, 2018 [JGAAP]

FY2018 Financial Result <Supplement>

Fuji Heavy Industries Ltd.

Summary of Consolidated Financial Results in the Third Quarter of the Fiscal Year Ending March 2007

Consolidated Financial Results for the Year Ended March 31, 2018

Financial Report for 3 rd Quarter of FY (April 2010 December 2010)

Net sales Operating income Ordinary income

Summary of Consolidated Financial Results in the First Quarter of the Fiscal Year Ending March 2007

Explanation of Financial Results. May 12, 2010 Toshikazu Tanaka President & CEO

Financial Results & Outlook for FY2012

Fully diluted net income per share Dividend per share (Record date) End of 1Q End of 2Q End of 3Q Year-end Annual

millions of yen % yen yen % Year ended March 31, ,

[Translation] Code number: 1963 Representative Title: Representative Director, Chairman and Chief Executive Officer (CEO) Tel:

Review and Analysis of Consolidated Results for Fiscal 2016 Fiscal year ended March 31, 2017

Third Quarter of FY 2017

Highlights of Consolidated Results for the First Half and the Second Quarter of Fiscal Year ending March 31, 2016

2Q of FY ended December 31, 2015 Restated basis *1. Year-on year change (Restated basis) 2Q of FY ending December 31, 2016 Forecast

Consolidated Financial Results for the First Half of the Fiscal Year Ending March 31, 2012

Business Results for the First Quarter of the Fiscal Year Ending December 31, 2018 (Unaudited)

Flash Report for the Fiscal Year Ended December 31, 2016 [Japan GAAP] (on a consolidated basis) February 13, 2017

11-Year Consolidated Financial Highlights

FY2010 Second Quarter Financial Results. SUZUKI MOTOR CORPORATION 2 November 2010

FY2017 SECOND QUARTER FINANCIAL RESULTS BRIEFING

Highlights of Consolidated Results for Fiscal Year ended March 31, 2016

Consolidated Financial Results for the 1 st Half of FYE 2019

Consolidated Financial Statements - Summary (For the fiscal year ended March 31, 2008) May 16, 2008

SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS FOR THE SECOND QUARTER OF THE FISCAL YEAR ENDING NOVEMBER 30, 2015 [JAPAN GAAP]

Presentation of Business Results for the 1st Quarter of FYE 2014

FY2014 Earnings Presentation (Overview)

ANNOUNCEMENT OF FINANCIAL RESULTS

Summary of Consolidated Financial Statements for the Nine Months ended September 30,2012 (Japanese GAAP)

Flash Report Consolidated Basis Results for the First Half of Fiscal 2017 (April 1, 2017 September 30, 2017) <under Japanese GAAP>

millions of yen millions of yen % September 30, ,135, ,

FY ending. 3Q of FY ended December 31, 2015 Restated basis *1. Year-on-year change (Restated basis) 3Q of FY ending

2. Notes. (2) Consolidated financial positions

Business Results for the Second Quarter of the Fiscal Year Ending December 31, 2018 (Unaudited)

Highlights of Consolidated Results for the First Half and the Second Quarter of Fiscal Year ending March 31, 2018

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012

Flash Report for the Fiscal Year ended December 31, 2013 [Japan GAAP] (on a consolidated basis)

millions of yen millions of yen % December 31, ,368, ,

Flash Report Consolidated Basis Results for the First Quarter of Fiscal 2018 (April 1, 2018 June 30, 2018) <under Japanese GAAP>

As of March As of December 31, , 2012 Change In billions of yen In billions of yen % Total assets 2, , Net assets

JTG Consolidated financial results for 2014 and forecasts for fiscal year Naohiro Minami. CFO and Senior Vice President

Consolidated Balance Sheets As of June 30,2007,2006 and December 31,2006

Consolidated Financial Results for the Nine Months Ended December 31, 2011

Revenue Operating profit Profit before tax Profit. Millions of Yen. Return on equity attributable to owners of the parent. Diluted earnings per share

Transcription:

Financial Summary Results for 3 rd Quarter of FY2018 & Outlook for FY2018 Mitsui Chemicals, Inc. February 5, 2019 <Remarks> FY2018 indicates the period from April 1, 2018 to March 31, 2019.

Contents 1. Results for 3rd Quarter of FY2018 (April 1, 2018 December 31, 2018) 1) Review on 3rd Quarter of FY2018 (Business Overview and Topics) 1, 2 2) Consolidated Financial Highlights 3, 4 3) Net sales and Operating Income/Loss by Business Segment (compared with corresponding period of FY2017 results) 5 4) Non-Operating Income and Expenses, and Extraordinary Gains and Losses 6 5) Consolidated Balance Sheet 7 6) Consolidated Statement of Cash Flow 8 2. Outlook for FY2018 (April 1, 2018 March 31, 2019) 1) Topics for 4th Quarter of FY2018 9 2) Consolidated Financial Highlights of Outlook 10 3) Net sales and Operating Income/Loss by Business Segment (compared with FY2017 results) 4) Operating Income/Loss by Business Segment (compared with previous outlook) 11 12 5) Non-Operating Income and Expenses, and Extraordinary Gains and Losses 13, 14 6) Consolidated Statement of Cash Flow 15 3. Appendix 16~24 Please note that this document has been translated from the original Japanese into English for the convenience of our stakeholders. The information was originally provided in Japanese. If there is any discrepancy, the Japanese language version is the official document and is available on our Japanese language website.

1. Results for 3 rd Quarter of FY2018 (April 1, 2018 December 31, 2018)

1) Review on 3 rd Quarter of FY2018 (Business Overview and Topics) <Business Overview> - Mobility: Healthy demand continued for automotive applications in elastomers, performance compounds and polypropylene compounds mainly in overseas market. Healthy demand continued in performance polymers especially for information and communication technology applications. On the other hand, terms of trade was unfavorable due to upward swing in raw material prices. - Health Care: Sales for vision care materials and dental materials were stable. In nonwoven fabrics, sales were impacted by decreasing export of disposable diapers from Japan overall, but high performance grade products were stable. - Food & Packaging: Sales for coating & engineering materials, performance films & sheets and agrochemicals were steady, but terms of trade was unfavorable due to upward swing in raw material prices. - Basic Materials: Healthy domestic demand continued. Operating rates of naphtha crackers and other production facilities were lower than the same period of the previous fiscal year due to a fire at Osaka Works, but kept at high level overall. In phenols, the oversea market environment was at higher level than the same period of the previous fiscal year, backed by the firm demand. 1.Results for 3 rd Quarter of FY2018 1

1) Review on 3 rd Quarter of FY2018 (Business Overview and Topics) <Topics> - Commercial operations for high performance nonwovens at Nagoya Works in Japan (October 2018, 15,000 tons/annum) - Commercial operations for capacity expansion of premium high performance nonwovens in Japan (October 2018, +6,000 tons/annum) - Repurchase of Own Shares (November 2018) - Mitsui Chemicals Agro: Joint development of CYRA as herbicide for the paddy rice field with National Federation of Agricultural Cooperative Associations (November 2018) - Transferring a Portion of Shares in Siam Mitsui PTA and Thai PET Resin (December 2018) 1.Results for 3 rd Quarter of FY2018 2

2) Consolidated Financial Highlights (Billions of Yen) Items FY2017 FY2018 Increase (Decrease) % Net sales Operating income Non-operating incomes and expenses Ordinary income Extraordinary gains and losses Net income before income taxes and minority interests Profit attributable to owners of parent 959.8 1,114.8 155.0 16% 75.7 74.6 (1.1) (1%) 3.2 11.6 8.4 ー 78.9 86.2 7.3 9% 5.0 (5.2) (10.2) ー 83.8 81.0 (2.8) (3%) 60.9 57.9 (3.0) (5%) Exchange rate (Yen/US$) 112 111 (1) Domestic standard naphtha price (Yen/KL) 39,900 52,100 12,200 1.Results for 3 rd Quarter of FY2018 3

2) Consolidated Financial Highlights (Billions of Yen) Items End of Mar. 2018 End of Dec. 2018 Increase (Decrease) % Interest-bearing liabilities Interest-bearing liabilities (net) Equity Net D/E Ratio (Times) Equity Ratio (%) 463.7 477.6 13.9 3% 381.8 381.2 (0.6) (0%) 511.6 537.5 25.9 5% 0.75 0.71 (0.04) ー 35.7 36.3 0.6 ー (Number of companies) Items End of Mar. 2018 End of Dec. 2018 Increase (Decrease) Consolidated companies Consolidated subsidiaries 115 116 1 Non-consolidated subsidiaries and affiliates to which the equity method is applied 39 39 0 Total 154 155 1 1.Results for 3 rd Quarter of FY2018 4

3) Net sales and Operating Income/Loss by Business Segment (compared with corresponding period of FY2017 results) (Billions of Yen) Segment FY2017 Net sales FY2018 Incr. (Decr.) Operating Income/Loss FY2017 FY2018 Incr. (Decr.) Volume Breakdown Terms of trade Costs Mobility 234.8 294.5 59.7 32.9 31.5 (1.4) 2.9 (1.9) (2.4) Health Care 103.4 109.7 6.3 7.9 9.7 1.8 2.7 (1.2) 0.3 Food & Packaging 144.6 146.5 1.9 14.5 11.8 (2.7) 0.0 (1.5) (1.2) Basic Materials 459.0 545.7 86.7 26.5 27.5 1.0 0.0 7.1 (6.1) Others 18.0 18.4 0.4 (6.1) (5.9) 0.2 - - 0.2 Total 959.8 1,114.8 155.0 75.7 74.6 (1.1) 5.6 2.5 (9.2) 1.Results for 3 rd Quarter of FY2018 5

4) Non-Operating Income and Expenses, and Extraordinary Gains and Losses (Billions of Yen) Non-Operating Incomes and Expenses Items FY2017 FY2018 Incr. (Decr.) Equity in earnings of non-consolidated subsidiaries and affiliates 4.6 11.0 6.4 Interest expenses, interest and dividend income (1.1) (0.5) 0.6 Gain (loss) on foreign exchange 0.1 0.0 (0.1) Others (0.4) 1.1 1.5 Non-operating incomes and expenses total 3.2 11.6 8.4 (Billions of Yen) Extraordinary Gains and Losses Items FY2017 FY2018 Incr. (Decr.) Gain on sales of non-current assets & investment securities 3.5 3.5 0.0 Gain on transfer of business 0.6 0.7 0.1 Gain on forgiveness of debts 2.0 0.0 (2.0) Extraordinary gains (a) 6.1 4.2 (1.9) Loss on sales and disposal of non-current assets (1.1) (2.0) (0.9) Impairment loss 0.0 (0.9) (0.9) Loss on valuation of investment securities 0.0 (0.2) (0.2) Loss on fire 0.0 (6.3) (6.3) Extraordinary losses (b) (1.1) (9.4) (8.3) Extraordinary gains and losses total (a)+(b) 5.0 (5.2) (10.2) 1.Results for 3 rd Quarter of FY2018 6

5) Consolidated Balance Sheet (Billions of Yen) Items End of Mar. 2018 End of Dec. 2018 Incr. (Decr.) Items End of Mar. 2018 End of Dec. 2018 Incr. (Decr.) Current assets 731.3 786.8 55.5 Liabilities 844.1 865.1 21.0 Cash and deposits 80.2 96.4 16.2 Notes and accounts payables 162.2 176.6 14.4 Notes and accounts receivables 306.9 304.1 (2.8) Interest-bearing liabilities 463.7 477.6 13.9 Inventories 274.3 315.7 41.4 Other liabilities 218.2 210.9 (7.3) Other current assets 69.9 70.6 0.7 Fixed assets 700.0 692.8 (7.2) Net assets 587.2 614.5 27.3 Tangible fixed assets 432.9 432.0 (0.9) Shareholders' equity 485.6 515.1 29.5 Intangible fixed assets 31.5 29.6 (1.9) Other accumulated comprehensive income 26.0 22.4 (3.6) Investments and other non-current assets 235.6 231.2 (4.4) Non-controlling interests 75.6 77.0 1.4 Total 1,431.3 1,479.6 48.3 Total 1,431.3 1,479.6 48.3 Note: Consolidated balance sheet as of FY2017 is restated to reflect changes in presentation from including an impact of Partial Amendments to Accounting Standard for Tax Effect Accounting. 1.Results for 3 rd Quarter of FY2018 7

6) Consolidated Statement of Cash Flow (Billions of Yen) Items FY2017 FY2018 Incr. (Decr.) Ⅰ.Cash flows from operating activities (a) 58.4 67.4 9.0 Ⅱ.Cash flows from investing activities (b) (36.4) (32.2) 4.2 Free cash flows (a)+(b) 22.0 35.2 13.2 Ⅲ.Cash flows from financing activities (41.8) (20.3) 21.5 Ⅳ.Others (0.2) 0.1 0.3 Net incr.(decr.) in cash and cash equivalents (20.0) 15.0 35.0 1.Results for 3 rd Quarter of FY2018 8

2. Outlook for FY2018 (April 1, 2018 March 31, 2019) This summary contains forward-looking statements the future plans, strategies, belief and performance of the Mitsui Chemicals Group as a whole and its individual consolidated companies. These forward-looking statements are not historical facts. They are expectations, estimates, forecasts and projections based on information currently available to the Mitsui Chemicals Group and are subject to a number of risks, uncertainties and assumptions, which, without limitation, include economic trends, fluctuations in foreign currency exchange rates, fluctuations in the price of raw materials, competition in markets where the Company is active, personal consumption, market demand, the tax system and other legislation. As such, actual results may differ materially from those projected and the Mitsui Chemicals Group cannot guarantee that these forward-looking statements are accurate or will be achieved.

1) Topics for 4 th Quarter of FY2018 <Topics> - Production for α-methylstyrene in Singapore (January 2019, 20,000 tons/annum, Completion in May 2020) - Construction starts to expand facilities for thermoplastic olefinic elastomer Milastomer in North America (4 th Quarter of FY2018, 6,000 tons/annum, commercial operations in FY2019) 2. Outlook for FY2018 9

2) Consolidated Financial Highlights of Outlook (Billions of Yen) Net sales Items FY2017 (a) FY2018 Outlook (b) Incr.(Decr.) (b)-(a) FY2018 Previous Outlook (on Nov 1, 2018) Full Year Full Year Full Year % Full Year 959.8 1,328.5 1,114.8 1,495.0 166.5 13% 1,540.0 Operating income Non-operating incomes and expenses Ordinary income Extraordinary gains and losses Net income before income taxes and minority interests Profit attributable to owners of parent 75.7 103.5 74.6 100.0 (3.5) (3%) 106.0 3.2 6.7 11.6 10.0 3.3-11.0 78.9 110.2 86.2 110.0 (0.2) (0%) 117.0 5.0 (16.0) (5.2) (2.0) 14.0 - (9.0) 83.8 94.2 81.0 108.0 13.8 15% 108.0 60.9 71.6 57.9 80.0 8.4 12% 80.0 Exchange rate (Yen/US$) 112 111 111 111 0 110 Domestic standard naphtha price (Yen/KL) 39,900 41,900 52,100 49,100 7,200 54,600 Dividend (Yen/Share) 2. Outlook for FY2018 Interim Year-end Interim Year-end Interim Year-end Year-end * 45 45 50 50 5 5 50 Full year 90 Full year 100 Full year 10 10 Full year 100 *The Group conducted 5-to-1 share consolidation on October 1, 2017. The dividend for FY2017 Interim is calculated assuming the share consolidation retrospectively.

3) Net sales and Operating Income/Loss by Business Segment (compared with FY2017 results) (Billions of Yen) Segment Net sales Operating Income/Loss FY2017 FY2018 Outlook Incr.(Decr.) FY2017 FY2018 Outlook Incr.(Decr.) Full Year (a) Full Year (b) (b) - (a) Full Year (c) Full Year (d) (d) - (c) Mobility 234.8 331.0 294.5 396.0 65.0 32.9 42.3 31.5 43.0 0.7 Health Care 103.4 139.1 109.7 147.0 7.9 7.9 10.8 9.7 13.5 2.7 Food & Packaging Basic Materials 144.6 195.8 146.5 203.0 7.2 14.5 19.9 11.8 20.5 0.6 459.0 637.7 545.7 724.0 86.3 26.5 38.9 27.5 31.0 (7.9) Others 18.0 24.9 18.4 25.0 0.1 (6.1) (8.4) (5.9) (8.0) 0.4 Total 959.8 1,328.5 1,114.8 1,495.0 166.5 75.7 103.5 74.6 100.0 (3.5) 2. Outlook for FY2018 11

4) Operating Income/Loss by Business Segment (compared with previous outlook) (Billions of Yen) Segment Operating Income/Loss for FY2018 Previous Outlook (on Nov. 1, 2018) Current Outlook Incr. (Decr.) Comments [+] denotes profit trigger [-] denotes loss trigger Mobility 42.5 43.0 0.5 [+] Downward swing in raw material price, etc. Health Care 13.0 13.5 0.5 [+] Firm sales, Downward swing in raw material price, etc. Food & Packaging 21.5 20.5 (1.0) [-] Terms of trade, etc. Basic Materials 37.0 31.0 (6.0) [-] Terms of trade, etc. Others (8.0) (8.0) 0.0 Total 106.0 100.0 (6.0) 2. Outlook for FY2018 12

5) Non-Operating Income and Expenses, and Extraordinary Gains and Losses (Billions of Yen) Items FY2017 Full Year (a) FY2018 Outlook Full Year (b) Incr.(Decr.) (b) - (a) Equity in earnings of non-consolidated subsidiaries and affiliates 4.6 7.1 11.0 11.0 3.9 Interest expenses, interest and dividend income (1.1) (0.7) (0.5) (1.0) (0.3) Gain (loss) on foreign exchange 0.1 (1.2) 0.0 0.0 1.2 Others (0.4) 1.5 1.1 0.0 (1.5) Non-operating incomes and expenses total 3.2 6.7 11.6 10.0 3.3 2. Outlook for FY2018 13

5) Non-Operating Income and Expenses, and Extraordinary Gains and Losses (Billions of Yen) Items FY2017 Full Year (a) FY2018 Outlook Full Year (b) Incr.(Decr.) (b) - (a) Gain on sales of non-current assets & investment securities 3.5 3.6 3.5 3.5 (0.1) Gain on transfer of business 0.6 0.6 0.7 0.7 0.1 Gain on revision of retirement benefit plan 0.0 0.3 0.0 0.0 (0.3) Gain on forgiveness of debts 2.0 2.0 0.0 0.0 (2.0) Others 0.0 0.0 0.0 3.7 3.7 Extraordinary gains (a) 6.1 6.5 4.2 7.9 1.4 Loss on sales and disposal of non-current assets (1.1) (2.4) (2.0) (2.5) (0.1) Impairment loss 0.0 (15.0) (0.9) (0.9) 14.1 Loss on valuation of investment securities 0.0 (5.1) (0.2) (0.2) 4.9 Loss on fire 0.0 0.0 (6.3) (6.3) (6.3) Extraordinary losses (b) (1.1) (22.5) (9.4) (9.9) 12.6 Extraordinary gains and losses Total (a)+(b) 5.0 (16.0) (5.2) (2.0) 14.0 2. Outlook for FY2018 14

6) Consolidated Statement of Cash Flow (Billions of Yen) Items FY2017 Full Year (a) FY2018 Outlook Full Year (b) Incr.(Decr.) (b) - (a) Ⅰ.Cash flows from operating activities (a) 58.4 82.7 67.4 100.0 17.3 Ⅱ.Cash flows from investing activities (b) (36.4) (75.1) (32.2) (75.0) 0.1 Free cash flows (a)+(b) 22.0 7.6 35.2 25.0 17.4 Ⅲ.Cash flows from financing activities (41.8) (10.2) (20.3) (25.0) (14.8) Ⅳ.Others (0.2) (1.5) 0.1 0.0 1.5 Net incr.(decr.) in cash and cash equivalents (20.0) (4.1) 15.0 0.0 4.1 2. Outlook for FY2018 15

3. Appendix 1) Trends in Product Prices 2) Increase/Decrease in Business Segment (Net sales and Operating Income, year on year) 3) Net sales and Operating Income/Loss by Business Segment (by Quarter) 4) Financial Summary 5) Net sales by Region This summary contains forward-looking statements the future plans, strategies, belief and performance of the Mitsui Chemicals Group as a whole and its individual consolidated companies. These forward-looking statements are not historical facts. They are expectations, estimates, forecasts and projections based on information currently available to the Mitsui Chemicals Group and are subject to a number of risks, uncertainties and assumptions, which, without limitation, include economic trends, fluctuations in foreign currency exchange rates, fluctuations in the price of raw materials, competition in markets where the Company is active, personal consumption, market demand, the tax system and other legislation. As such, actual results may differ materially from those projected and the Mitsui Chemicals Group cannot guarantee that these forward-looking statements are accurate or will be achieved.

1) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan) : Change in Prices and Raw Materials Prices in Japan / BPA(China), PTA, TDI : Chinese Market Price) (ACP) : Asian contract price Year 2016 2017 2018 Month Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec. Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec. Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec. Naphtha (Yen/KL) 34,300 31,600 31,300 34,100 41,900 39,100 36,100 44,600 47,900 48,700 53,500 54,200 PE (Yen/KG) PP (Yen/KG) PH (Formula Price) (Yen/KG) (10) (10) (10) (10) +20 +20 (5) (5) +10 +10 +10 +10 +10 +10 +10 +10 BZ(ACP) (US$/T) BPA(Japan) (Yen/KG) BPA (China) (US$/T) PTA (US$/T) PX(ACP) (US$/T) TDI (US$/T) $560 $640 $640 $670 $950 $790 $770 $830 $920 $850 $860 $770 +20 From Mar. negotiation based on BZ price and BPA market price $940 $1,140 $1,130 $1,170 $1,360 $1,200 $1,220 $1,420 $1,670 $1,800 $1,810 $1,550 $570 $610 $610 $610 $670 $630 $640 $690 $760 $810 $960 $910 $720 $800 $790 $790 $890 $810 $800 $890 $950 $980 $1,140 $1,140 $1,510 $2,080 $2,360 $3,590 $3,480 $3,500 $3,680 $4,380 $4,470 $4,150 $3,400 $2,480 3. Appendix 16

2-1) Increase/Decrease in Mobility (Net sales and Operating Income, year on year) Increase/Decrease of Net Sales (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) (Unit:Billions of yen) +59.7 Volume +45.9 billion yen - Prompt response to healthy global automotive use demand. - Prompt response to healthy demand for information and communication technology applications. - Acquisition of shares of ARRK corporation in 4Q of FY2017, etc. Prices +13.8 billion yen - Increase from sales price revision in line with upward swing in raw material prices, etc. Increase/Decrease of Operating Income (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) Unit:Billions of yen) (1.4) Volume +2.9 billion yen - Prompt response to healthy global automotive use demand. - Prompt response to healthy demand for information and communication technology applications. Terms of trade (1.9) billion yen - Decrease from unfavorable terms of trade due to upward swing in raw material prices, etc. Costs (2.4) billion yen - Development costs. - Acquisition of shares of ARRK corporation in 4Q of FY2017, etc. 3. Appendix 17

2-2) Increase/Decrease in Health Care (Net sales and Operating Income, year on year) Increase/Decrease of Net Sales (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) (Unit:Billions of yen) +6.3 Volume +5.2 billion yen - Stable sales of vision care materials and dental materials. Prices +1.1 billion yen Increase/Decrease of Operating Income (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) Unit:Billions of yen) +1.8 Volume +2.7 billion yen - Stable sales of vision care materials and dental materials. Terms of trade (1.2) billion yen - Decrease from unfavorable terms of trade due to upward swing in raw material prices, etc. Costs +0.3 billion yen - Decrease in goodwill amortization expenses of dental materials, etc. 3. Appendix 18

2-3) Increase/Decrease in Food & Packaging (Net sales and Operating Income, year on year) Increase/Decrease of Net Sales (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) (Unit:Billions of yen) Volume (1.6) billion yen +1.9 Prices +3.5 billion yen - Increase from sales price revision in line with upward swing in raw material prices, etc. Increase/Decrease of Operating Income (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) Unit:Billions of yen) Volume +0.0 billion yen (2.7) Terms of trade (1.5) billion yen - Decrease from unfavorable terms of trade due to upward swing in raw material prices, etc. Costs (1.2) billion yen - Development costs, etc. 3. Appendix 19

2-4) Increase/Decrease in Basic Materials (Net sales and Operating Income, year on year) Increase/Decrease of Net Sales (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) (Unit:Billions of yen) Volume +14.4 billion yen +86.7 Prices +72.3 billion yen - Increase from sales price revision in line with upward swing in raw material prices, etc. Increase/Decrease of Operating Income (3 rd Quarter of FY2018 vs. 3 rd Quarter of FY2017) (Unit:Billions of yen) Volume +0.0 billion yen +1.0 Terms of trade +7.1 billion yen - Market price of phenol, etc. Costs (6.1) billion yen - Cost increase due to a fire at Osaka works, etc. 3. Appendix 20

3) Net sales and Operating Income/Loss by Business Segment (by Quarter) Net sales Segment (Billions of Yen) FY2017 FY2018 Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Mobility 77.7 75.7 81.4 96.2 97.3 97.9 99.3 Health Care 34.2 33.9 35.3 35.7 36.2 35.0 38.5 Food & Packaging 45.8 49.2 49.6 51.2 47.5 49.1 49.9 Basic Materials 145.3 146.9 166.8 178.7 170.1 176.2 199.4 Others 6.0 6.2 5.8 6.9 5.2 6.4 6.8 Total 309.0 311.9 338.9 368.7 356.3 364.6 393.9 Operating Income/Loss (Billions of Yen) Segment FY2017 FY2018 Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Mobility 11.5 10.5 10.9 9.4 10.8 9.3 11.4 Health Care 2.9 1.9 3.1 2.9 3.6 2.7 3.4 Food & Packaging 4.6 5.5 4.4 5.4 3.3 5.5 3.0 Basic Materials 10.8 4.6 11.1 12.4 11.0 7.4 9.1 Others (2.5) (1.6) (2.0) (2.3) (2.4) (1.5) (2.0) Total 27.3 20.9 27.5 27.8 26.3 23.4 24.9 3. Appendix 21

4-1) Financial Summary 1,750 1,500 (Billion Yen) Net Sales 1,566.0 1,550.1 1,454.0 1,406.2 1,343.9 1,328.5 1,495.0 (Billion Yen) 1,600 Total Assets *1 1,432.2 1,411.8 1,431.3 1,400 1,338.0 1,325.5 1,256.3 1,258.9 1,250 1,212.3 1,200 1,0000 1,0000 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook) 80.0 60.0 40.0 20.0 0.0 (20.0) (40.0) 21.6 Operating Income & Profit attributable to owners of parent (Billion Yen) 120.0 Operating Income 100.0 owners of parent 42.0 (1.0) Profit attributable to 4.3 (8.1) 24.9 (25.1) 17.3 70.9 23.0 102.1 103.5 100.0 64.8 71.6 80.0 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook) 3.Appendix 22 (100.0) '11 '12 '13 '14 '15 '16 '17 *1.Consolidated balance sheet as of FY2017 is restated to reflect changes in presentation from including an impact of Partial Amendments to Accounting Standard for Tax Effect Accounting. Cash Flows (Billion Yen) 150.0 Operating CF 145.9 Investing CF 100.4 100.0 109.5 FCF 82.7 50.0 58.3 100.0 43.3 43.5 53.0 18.5 23.3 25.0 0.0 0.8 (39.6) (46.3) (35.0) 7.6 (36.4) (47.4) (42.5) (58.1) (75.1) (50.0) (75.0) (89.8) '11 '12 '13 '14 '15 '16 '17 '18 (Outlook)

4-2) Financial Summary Capital Expenditure (Billion Yen) 113.2 120.0 *1 *2 100.0 81.2 74.0 80.0 56.6 60.0 44.8 47.5 43.4 45.4 40.0 20.0 0.0 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook) *1. Include Heraeus dental business acquisition 56.0 billion yen *2. Include acquisition of shares of ARRK corporation 23.9 billion yen 80.0 60.0 40.0 20.0 0.0 Depreciation & Amortization (Billion Yen) 62.7 43.8 48.1 48.2 48.6 44.1 45.7 50.0 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook) 50.0 (Billion Yen) R&D Resources (Billion Yen) 1,000 Net D/E Ratio Net Interest-bearing Liabilities 40.0 30.0 33.2 32.0 33.6 32.5 31.5 30.8 33.4 36.0 800 600 1.12 1.22 1.44 1.22 Equity Net D/E Ratio 1.03 1.60 1.20 20.0 10.0 400 200 0.79 0.75 0.70 0.80 0.0 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook) 3.Appendix 23 0 0.40 '11 '12 '13 '14 '15 '16 '17 '18 (Outlook)

5) Net sales by Region Overseas Sales 44% Europe 6% Americas 12% Overseas Sales 45% Europe 7% Americas 12% Asia* 14% FY2017 Consolidated Sales 1,328.5 billion Japan 56% Asia* 14% FY2018 Consolidated Sales 1,114.8 billion Japan 55% China 11% China 12% * Asia excluding Japan and China 3.Appendix 24

Creating New Customer Value and Solving Social Challenges through Business Activities